# N-Acetylcysteine Roles in Preserving Renal Function Measured by Urinary KIM-1 (Kidney Injury Molecule-1) and Serum Creatinine on Cancer Patients With Cisplatin Based Chemotherapy: A Randomized Placebo-Controlled Trial

> **NCT07156786** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Fakultas Kedokteran Universitas Indonesia** · enrollment: 72 (estimated)

## Conditions studied

- Kidney Function Issue
- Acute Kidney Injury
- Cancer (Solid Tumors)
- Kidney Function Tests
- Acetylcysteine Adverse Reaction

## Interventions

- **DRUG:** N-acetylcysteine (NAC)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07156786
- **Lead sponsor:** Fakultas Kedokteran Universitas Indonesia
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-15
- **Primary completion:** 2027-04-30
- **Final completion:** 2027-08-31
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07156786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07156786, "N-Acetylcysteine Roles in Preserving Renal Function Measured by Urinary KIM-1 (Kidney Injury Molecule-1) and Serum Creatinine on Cancer Patients With Cisplatin Based Chemotherapy: A Randomized Placebo-Controlled Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07156786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*